The devastating impact of respiratory infections demonstrates the critical need for novel prophylactic vaccines. In this opinion article, we advocate for bacterial immunotherapies as a complementary tool in our fight against respiratory infections.
Neuroendocrine neoplasms (NENs) comprise a group of rare tumors originating from neuroendocrine cells, which are present in both endocrine glands and scattered throughout the body.
Pfizer Foundation awards our laboratory with the “Premio Fundación Pfizer – ITEMAS al mejor proyecto de innovación en salud surgido de las Unidades y Unidades Asociadas de la Plataforma ITEMAS-ISCIII”. This award recognized the value of our project regarding the use of blood liquid biopsy to identify patients suffering from colon polyps or tumors. Beyond…
Continuing with our efforts to bring the results generated in the lab to our patients, and in line with our previous achievement granted by ASEICA-La Caixa, we have been selected by Fundación Parque Científico de Madrid as part of the program APTEnisa Start 2024. We continue pushing our project focused on a blood-based liquid biopsy…
Selected by ASEICA – La Caixa In our lab, as part of the research line where we are looking for cancer biomarkers, we are developing a project for the establishment of a blood-based liquid biopsy to identify patients suffering from colon polyps or tumors. As a translational laboratory, we aim to bring our research…
For decades, innate immune cells were considered unsophisticated first responders, lacking the adaptive memory of their T and B cell counterparts. However, mounting evidence demonstrates the surprising complexity of innate immunity.
Trained immunity (TI) represents a memory-like process of innate immune cells. TI can be initiated with various compounds such as fungal b-glucan or the tuberculosis vaccine, Bacillus Calmette-Gue´ rin.
Intravesical administration of Bacillus Calmette-Guérin (BCG) was one of the first FDA-approved immunotherapies and remains a standard treatment for bladder cancer.
#WCRD2023 Every 24th of September we celebrate the World Cancer Research Day #WCRD. This year, we have participated in some activities trying to visualize our labor in this topic, sponsored by the Spanish association against cancer (AECC). Check it out some of these activities. https://www.contraelcancer.es/es/eventos/accion-calle-plaza-chamberi-madrid-celebrar-dia-mundial-investigacion-cancer-0 https://www.atresplayer.com/lasexta/programas/que-me-pasa-doctor-lasexta/temporada-1/programa-297-cancer-psoriasis_6508796b7152b0e49dd02eb6/
We have performed an integral and longitudinal study of the immunological responses triggered by the booster mRNA-1273 vaccination